More vaccine efficacy studies on the recombinant bacille calmette-guerin co-expressing Ag85B, Mpt64 190-198 and Mtb8.4

Scandinavian Journal of Immunology

Volumn 69, Issue 4, 2009, Pages 342-350

  Qie, Y Q ^a   Wang, J L ^a   Liu, W ^a   Shen, H ^a   Chen, J Z ^a   Zhu, B D ^b   Xu, Y ^a   Zhang, X L ^a   Wang, H H ^a  

^a FUDAN UNIVERSITY   (China)

^b LANZHOU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; RECOMBINANT BACILLUS CALMETTE GUERIN AG85B FUSION PROTEIN; RECOMBINANT BACILLUS CALMETTE GUERIN AG85B MPT64[190-198] MTB8.4 FUSION PROTEIN; RECOMBINANT VACCINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HISTOPATHOLOGY; IMMUNE RESPONSE; IMMUNOGENICITY; MOUSE; MYCOBACTERIOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANTIGENS, BACTERIAL; BCG VACCINE; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; MICE; MICE, INBRED C57BL; MYCOBACTERIUM TUBERCULOSIS; RECOMBINANT FUSION PROTEINS; TUBERCULOSIS; VACCINES, SYNTHETIC;

EID: 61849106380     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2009.02231.x     Document Type: Article

References (31)

1. Dolin PJ, Raviglione MC, Kochi A. Global tuberculosis incidence and mortality during 1990-2000. Bull World Health Organ 1994 72 : 213 20.
2. Bao L, Chen W, Zhang H, Wang X. Virulence, immunogenicity, and protective efficacy of two recombinant Mycobacterium bovis bacillus Calmette-Guerin strains expressing the antigen ESAT-6 from Mycobacterium tuberculosis. Infect Immun 2003 71 : 1656 61.
3. Calmette A, Gue′rin C, Ne'gre L, Boquet A. Pre′munition des nouveaux-ne′s contre la tuberculose par le vaccin BCG, 1921-1926. Ann Inst Pasteur (Paris) 1926 40 : 89 133.
4. WHO. Tuberculosis prevention trials: Madras. Trial of BCG vaccines in South India for tuberculosis prevention. Bull World Health Organ 1979 57 : 819 27.
5. Lagranderie MR, Balazuc AM, Deriaud E, Leclerc CD, Gheorghiu M. Comparison of immune responses of mice immunized with five different Mycobacterium bovis BCG vaccine strains. Infect Immun 1996 64 : 1 9.
6. Colditz GA, Brewer TF, Berkey CS et al. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA 1994 271 : 698 702.
7. Fine PE. Variation in protection by BCG: implications of and for heterologous immunity. Lancet 1995 346 : 1339 45.
8. WHO. Trial of BCG vaccines in south India for tuberculosis prevention: first report - Tuberculosis Prevention Trial. Bull World Health Organ 1979 57 : 819 27.
9. Andersen P, Andersen AB, Sorensen AL, Nagai S. Recall of long-lived immunity to Mycobacterium tuberculosis infection in mice. J Immunol 1995 154 : 3359 72.
10. Andersen P, Askgaard D, Gottschau A, Bennedsen J, Nagai S, Heron I. Identification of immunodominant antigens during infection with Mycobacterium tuberculosis. Scand J Immunol 1992 36 : 823 31.
11. Andersen P, Heron I. Specificity of a protective memory immune response against Mycobacterium tuberculosis. Infect Immun 1993 61 : 844 51.
12. Cooper AM, Dalton DK, Stewart TA, Griffin JP, Russell DG, Orme IM. Disseminated tuberculosis in interferon gamma gene-disrupted mice. J Exp Med 1993 178 : 2243 7.
13. D'Souza S, Denis O, Scorza T, Nzabintwali F, Verschueren H, Huygen K. CD4+ T cells contain Mycobacterium tuberculosis infection in the absence of CD8+ T cells in mice vaccinated with DNA encoding Ag85A. Eur J Immunol 2000 30 : 2455 9.
14. Brandt L, Elhay M, Rosenkrands I, Lindblad EB, Andersen P. ESAT-6 subunit vaccination against Mycobacterium tuberculosis. Infect Immun 2000 68 : 791 5.
15. Coler RN, Campos-Neto A, Ovendale P et al. Vaccination with the T cell antigen Mtb 8.4 protects against challenge with Mycobacterium tuberculosis. J Immunol 2001 166 : 6227 35.
16. Tanghe A, D'Souza S, Rosseels V et al. Improved immunogenicity and protective efficacy of a tuberculosis DNA vaccine encoding Ag85 by protein boosting. Infect Immun 2001 69 : 3041 7.
17. Vordermeier HM, Coombes AG, Jenkins P et al. Synthetic delivery system for tuberculosis vaccines: immunological evaluation of the M. tuberculosis 38 kDa protein entrapped in biodegradable PLG microparticles. Vaccine 1995 13 : 1576 82.
18. Hovav AH, Fishman Y, Bercovier H. Gamma interferon and monophosphoryl lipid A-trehalose dicorynomycolate are efficient adjuvants for Mycobacterium tuberculosis multivalent acellular vaccine. Infect Immun 2005 73 : 250 7.
19. Olsen AW, Williams A, Okkels LM, Hatch G, Andersen P. Protective effect of a tuberculosis subunit vaccine based on a fusion of antigen 85B and ESAT-6 in the aerosol guinea pig model. Infect Immun 2004 72 : 6148 50.
20. Li H, Ulstrup JC, Jonassen TO, Melby K, Nagai S, Harboe M. Evidence for absence of the MPB64 gene in some substrains of Mycobacterium bovis BCG. Infect Immun 1993 61 : 1730 4.
21. Feng CG, Demangel C, Kamath AT, Macdonald M, Britton WJ. Dendritic cells infected with Mycobacterium bovis bacillus Calmette Guerin activate CD8(+) T cells with specificity for a novel mycobacterial epitope. Int Immunol 2001 13 : 451 8.
22. (190-198)-mtb8.4 in C57/BL6 mice. Scand J Immunol 2008 67 : 133 9.
23. Brown CA, Brown IN. Mycobacterium bovis, BCG, modulation of murine antibody responses: influence of dose and degree of aggregation of live or dead organisms. Br J Exp Pathol 1982 63 : 133 43.
24. Xu Y, Zhu B, Wang Q et al. Recombinant BCG coexpressing Ag85B, ESAT-6 and mouse-IFN-gamma confers effective protection against Mycobacterium tuberculosis in C57BL/6 mice. FEMS Immunol Med Microbiol 2007 51 : 480 7.
25. Mustafa T, Phyu S, Nilsen R, Jonsson R, Bjune G. A mouse model for slowly progressive primary tuberculosis. Scand J Immunol 1999 50 : 127 36.
26. Palendira U, Spratt JM, Britton WJ, Triccas JA. Expanding the antigenic repertoire of BCG improves protective efficacy against aerosol Mycobacterium tuberculosis infection. Vaccine 2005 23 : 1680 5.
27. Nasser Eddine A, Kaufmann SH. Improved protection by recombinant BCG. Microbes Infect 2005 7 : 939 46.
28. Chackerian AA, Perera TV, Behar SM. Gamma interferon-producing CD4+ T lymphocytes in the lung correlate with resistance to infection with Mycobacterium tuberculosis. Infect Immun 2001 69 : 2666 74.
29. Kaufmann SH. How can immunology contribute to the control of tuberculosis? Nat Rev Immunol 2001 1 : 20 30.
30. Canaday DH, Wilkinson RJ, Li Q, Harding CV, Silver RF, Boom WH. CD4(+) and CD8(+) T cells kill intracellular Mycobacterium tuberculosis by a perforin and Fas/Fas ligand-independent mechanism. J Immunol 2001 167 : 2734 42.
31. Serbina NV, Flynn JL. CD8(+) T cells participate in the memory immune response to Mycobacterium tuberculosis. Infect Immun 2001 69 : 4320 8.